Page last updated: 2024-10-15

2',3'-dideoxyguanosine

Cross-References

ID SourceID
PubMed CID135463029
CHEMBL ID78101
SCHEMBL ID3162
MeSH IDM0143530

Synonyms (20)

Synonym
CHEMBL78101
guanosine, 2',3'-dideoxy-
2-amino-9-[(2r,5s)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-purin-6-one
dideoxyguanosine
2',3'-dideoxyguanosine ,
85326-06-3
ddguo
2-amino-9-((2r,5s)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1h-purin-6(9h)-one
A841294
AKOS015896853
SCHEMBL3162
DTXSID20234527
deoxy-deoxy-guanosine
OCLZPNCLRLDXJC-NTSWFWBYSA-N
W-203947
AC-32183
mfcd00057074
2', 3'-dideoxyguanosine
2-amino-9-[(2r,5s)-5-(hydroxymethyl)oxolan-2-yl]-1h-purin-6-one
AS-77442

Toxicity

ExcerptReference
" This suggests that PNA could pose a very low risk for adverse mitochondrion-related effects."( Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.
Chen, H; Hu, M; Jiang, Z; Li, Z; Tao, Y; Xiong, Y; Zhang, L; Zhang, P, 2011
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID32212Concentration required to inhibit the cytopathic effect of HIV-1 on ATH8 cells1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
AID297672Antimycobacterial activity against Mycobacterium tuberculosis H37Ra at 100 uM by microplate alamar blue assay2007Journal of medicinal chemistry, Sep-20, Volume: 50, Issue:19
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
AID83567Tested for the determination of percentage protection atuM against HIV-1 in ATH8 Cells1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
AID152790The antiviral activity against HIV-1 in human peripheral blood mononuclear (PBM) cells expressed as inhibitory concentration1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents.
AID83536Tested for the determination of percentage toxicity at 10 uM against HIV-1 in ATH8 cells1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
AID152634The antiviral activity against HIV-1 in human peripheral blood mononuclear (PBM) cells expressed as median effective concentration1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents.
AID31904In vitro effective dose which provides 50% protection of ATH-8 cells against the cytopathic effect of HIV; Range 5-10 uM1992Journal of medicinal chemistry, Jun-26, Volume: 35, Issue:13
Synthesis and anti-HIV activity of isonucleosides.
AID83540Tested for the determination of percentage toxicity at 2 uM against HIV-1 in ATH8 cells1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
AID83542Tested for the determination of percentage toxicity at 500 uM against HIV-1 in ATH8 cells1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
AID297680Antimycobacterial activity against Mycobacterium avium ATCC 25291 at 100 uM by microplate alamar blue assay2007Journal of medicinal chemistry, Sep-20, Volume: 50, Issue:19
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
AID31902In vitro cytotoxicity against uninfected ATH-8 (human T-cell) cell line.1992Journal of medicinal chemistry, Jun-26, Volume: 35, Issue:13
Synthesis and anti-HIV activity of isonucleosides.
AID297676Antimycobacterial activity against Mycobacterium bovis BCG at 100 uM by microplate alamar blue assay2007Journal of medicinal chemistry, Sep-20, Volume: 50, Issue:19
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
AID32208Concentration required to suppress the growth of target ATH8 cells1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
AID32214Concentration required to inhibit the cytopathic effect of HIV-2 on ATH8 cells; ND=Not determined1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
AID83568Tested for the determination of percentage protection atuM against HIV-1 in ATH8 cells1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
AID83559Tested for the determination of percentage protection at 10 uM against HIV-1 in ATH81990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
AID83402Tested for the determination of percentage toxicity at 100 uM against HIV-1 in ATH8 cells1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
AID21084Compound was evaluated for the partition coefficient measured for 1-octanol and 0.01 M potassium phosphate buffer (pH 7.0)1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
AID234489ratio of CD50/ED501991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
AID231376Ratio value is CD50/ED50; ND=Not determined1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
AID83558Tested for the determination of percentage protection at 100 uM against HIV-1 in ATH8 cells1990Journal of medicinal chemistry, May, Volume: 33, Issue:5
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.70)18.7374
1990's22 (81.48)18.2507
2000's2 (7.41)29.6817
2010's2 (7.41)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]